Bone‐on‐a‐chip: microfluidic technologies and microphysiologic models of bone tissue
A Mansoorifar, R Gordon, RC Bergan… - Advanced functional …, 2021 - Wiley Online Library
Bone is an active organ that continuously undergoes an orchestrated process of remodeling
throughout life. Bone tissue is uniquely capable of adapting to loading, hormonal, and other …
throughout life. Bone tissue is uniquely capable of adapting to loading, hormonal, and other …
Characterization of fibrin and collagen gels for engineering wound healing models
O Moreno-Arotzena, JG Meier, C Del Amo… - Materials, 2015 - mdpi.com
Hydrogels are used for 3D in vitro assays and tissue engineering and regeneration
purposes. For a thorough interpretation of this technology, an integral biomechanical …
purposes. For a thorough interpretation of this technology, an integral biomechanical …
Designing hydrogel-based bone-on-chips for personalized medicine
The recent development of bone-on-chips (BOCs) holds the main advantage of requiring a
low quantity of cells and material, compared to traditional In Vitro models. By incorporating …
low quantity of cells and material, compared to traditional In Vitro models. By incorporating …
From individual to collective 3D cancer dissemination: roles of collagen concentration and TGF-β
J Plou, Y Juste-Lanas, V Olivares, C Del Amo… - Scientific reports, 2018 - nature.com
Cancer cells have the ability to migrate from the primary (original) site to other places in the
body. The extracellular matrix affects cancer cell migratory capacity and has been correlated …
body. The extracellular matrix affects cancer cell migratory capacity and has been correlated …
Degradation of extracellular matrix regulates osteoblast migration: A microfluidic-based study
N Movilla, C Borau, C Valero, JM García-Aznar - Bone, 2018 - Elsevier
Bone regeneration is strongly dependent on the capacity of cells to move in a 3D
microenvironment, where a large cascade of signals is activated. To improve the …
microenvironment, where a large cascade of signals is activated. To improve the …
Fibroblast migration in 3D is controlled by haptotaxis in a non-muscle myosin II-dependent manner
O Moreno-Arotzena, C Borau, N Movilla… - Annals of Biomedical …, 2015 - Springer
Cell migration in 3D is a key process in many physiological and pathological processes.
Although valuable knowledge has been accumulated through analysis of various 2D …
Although valuable knowledge has been accumulated through analysis of various 2D …
A microfluidic-based analysis of 3D macrophage migration after stimulation by Mycobacterium, Salmonella and Escherichia
S Pérez-Rodríguez, C Borau, JM García-Aznar… - BMC microbiology, 2022 - Springer
Macrophages play an essential role in the process of recognition and containment of
microbial infections. These immune cells are recruited to infectious sites to reach and …
microbial infections. These immune cells are recruited to infectious sites to reach and …
Polydopamine Interfacial Coating for Stable Tumor-on-a-Chip Models: Application for Pancreatic Ductal Adenocarcinoma
S Hernández-Hatibi, PE Guerrero… - …, 2024 - ACS Publications
Addressing current challenges in solid tumor research requires advanced in vitro three-
dimensional (3D) cellular models that replicate the inherently 3D architecture and …
dimensional (3D) cellular models that replicate the inherently 3D architecture and …
Quantifying 3D chemotaxis in microfluidic-based chips with step gradients of collagen hydrogel concentrations
Cell migration is an essential process involved in crucial stages of tissue formation,
regeneration or immune function as well as in pathological processes including tumor …
regeneration or immune function as well as in pathological processes including tumor …
Cytotoxic responses of carnosic acid and doxorubicin on breast cancer cells in butterfly-shaped microchips in comparison to 2D and 3D culture
Two dimensional (2D) cell culture systems lack the ability to mimic in vivo conditions
resulting in limitations for preclinical cell-based drug and toxicity screening assays and …
resulting in limitations for preclinical cell-based drug and toxicity screening assays and …